Also in support of the notion that IL-1β promotes tumorigenesis, gain-of-function mutations in NLRP1 caused constitutive activation and secretion of IL-1β in keratinocytes, resulting in skin inflammation that made the patients more susceptible to skin cancer [137]. The gene discussed is IL1B; the disease is skin cancer.